Theralase Technologies as yet undiscoveredCouple of bullet points:
It trades on the Vancouver Exchange, no offense, but it is the minor of minor leagues as far as trading exchanges go.
It trades south of the border in the US on the OTC formerly known as the Pink Sheets.
The OTC is segmented into three tiers, with Theralase registered in the middle tier. The following is a snippet about the requirements for OTC QB listing:
The OTCQB market contains a one penny ($0.01) bid price requirement "intended to remove companies that are most likely to be the subject of dilutive stock fraud schemes and promotions". Each company verifies via an annual OTCQB Certification, signed by the company CEO or CFO, that their company information is current, including information about a company’s reporting status, company profile, information on management and boards, major shareholders, law firms, transfer agents, and IR / PR firms. Investor confidence improves when there is more information about a company’s ownership structure, professional advisors and service providers. This certification will be required for any security newly qualified to be publicly quoted by a broker-dealer under SEC Rule 15c2-11, or when a Pink traded company becomes a current SEC reporting company, beginning May 1, 2014. International Reporting companies are also allowed to upgrade from Pink to OTCQB if they publish their 12g3-2(b) compliant disclosure online and verify their company profile. There is an annual fee for the OTCQB market of $12,000 per year and a one-time $2,500 application fee.[17]
Continued next post